# Danhong Injection in the Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct01677208` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01677208](<https://clinicaltrials.gov/study/NCT01677208>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01677208

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1503 participants.

## Technical summary

Registry record NCT01677208. Randomized; quadruple masking; primary purpose treatment. Start 2013-03-13 (actual); primary completion 2019-03-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1503 participants (enrolled count; ClinicalTrials.gov record NCT01677208, source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)
- Started: 2013-03-13 (actual) (ClinicalTrials.gov record NCT01677208, source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)
- Primary completion: 2019-03-10 (actual) (ClinicalTrials.gov record NCT01677208, source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)
- Completion: 2019-03-27 (actual) (ClinicalTrials.gov record NCT01677208, source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01677208, source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01677208-2022-06-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Danhong Injection in the Treatment of Acute Ischemic Stroke
- Condition: Acute Stroke
- Intervention (Drug): Danhong injection
- Intervention (Procedure): Standard medical care
- Intervention (Drug): placebo
- Lead sponsor: China Academy of Chinese Medical Sciences
- Lead sponsor class: OTHER
- Collaborator: China Food and Drug Administration
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: China Academy of Chinese Medical Sciences (`cardio:org-china-academy-of-chinese-medical-sciences`)
- Registry lists this organization as a collaborator: China Food and Drug Administration (`cardio:org-china-food-and-drug-administration`)

## Provenance

Content hash: 272e0c234c00ce4214fa09494632c3ad791baf261df1d2b6917f30d7bbd8b617
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
